LDX 2.27% 4.5¢ lumos diagnostics holdings limited

The re-rate journey, page-80

  1. 84 Posts.
    lightbulb Created with Sketch. 2
    Would think that people are buying the 2023-4 story here rather than on last years results. Secured funding, fda approval and patents setting us up for massive sales and news flow in the next few months. Good luck to everyone on what's to come ...
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.